Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Buprenorphine/naloxone

Drug
Who is being recruted

Opioid-Related Disorders

From 14 to 21 Years
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: July 2003

Summary

Principal SponsorUniversity of Pennsylvania
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 2003Actual date on which the first participant was enrolled.

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Official TitleBup/Nx - Facilitated Rehab for Opioid Dependent Adolescents 
Principal SponsorUniversity of Pennsylvania
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
223 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
From 14 to 21 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Opioid-Related Disorders
Criteria

Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.


Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives


Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 4 locations
Suspended
Mercy HospitalPortland, United StatesSee the location
Suspended
Mountain ManorBaltimore, United States
Suspended
ASAPAlbuquerque, United States
Suspended
Duke Addictions ProgramDurham, United States

Completed4 Study Centers